Scientific activity

• Awarding of a clinical research project in cardiology by the Spanish Society of Cardiology: “Categorisation of cardiometabolic risk in pediatric patients with onco-haematological disease. Cardiac preparation programme in pediatric risk population”, 2019-2020.
• AF Almario-Hernández, M Boada Farràs, E Aurensanz Clemente, J Sanchez de Toledo. Breathing difficulties in the emergency department as a manifestation of a rare heart disease in children: anomalous origin of the left coronary artery in the pulmonary artery. An Pediatr (Barc), 2019.
• Aurensanz Clemente, E., Ayerza Casas, A., García Lasheras, C., Ramos Fuentes, F., Bueno Martínez, I., Pelegrín Díaz, J., Ruiz Frontera, P. and Montserrat Iglesias, L. Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3. Clin Case Rep. 2017; 5(3): 232-237.
• Aurensanz Clemente E, Ayerza Casas A, Samper Villagrasa P, Ruiz Frontera P; Bueno Lozano G. Assessment of cardiac function in a group of small-for-gestational-age school-age children receiving growth hormone treatment. Med Clin (Barc). 2017; 148(3): 101-106.
• Aurensanz Clemente E, Samper Villagrasa P, Ayerza Casas A, Ruiz Frontera P, Moreno Aznar LA, Bueno Lozano G. Body composition and metabolic risk in small-for-gestational-age children receiving growth hormone treatment. Med Clin (Barc). 2016; 147(6): 231-237.
• Aurensanz Clemente E, Samper Villagrasa P, et al. Modifications in anthropometric variables, metabolic risk analyses and body composition in small-for-gestational-age children receiving growth hormone treatment. An Pediatr (Barc). 2017; 86(5): 240-248.

See scientific activity